UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 4
April-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2404B45


Registration ID:
537827

Page Number

l326-l338

Share This Article


Jetir RMS

Title

Development and Validation of HPLC Method for the Estimation of Levofloxacin in Bulk and Marketed Dosage form

Abstract

Development and Validation of a High-Performance Liquid Chromatographic Analytical Procedure for Determining Levofloxacin in a Bulk and Marketed Dosage Formis described in this paper. The Separation was made with a C18 Symmetry (4.6 X 150mm,5μm) Column at ambient temperature, with isocratic mode and mobile phasePhosphate Buffer pH 2.8 : Acetonitrile 35:65 v/v. Eluent was monitored at 284nm and the flow rate was 1.0ml/min. LevofloxacinwaseffectivelySeparatedwithretentiontime(RT)of3.661minand5.116min respectively, within the selected chromatographic conditions. The Method was validated for AnalyticalParameters: Specificity, Linearity, Precision, Accuracyand Limits ofDetection and Quantitation. The Calibration curves were linear in the concentration range of 10 µg/ml for Levofloxacin and the Regression was found to be 0.995 respectively (NMT 0.999) for Levofloxacin. The % recovery for 50%, 100% and 150% accuracy level of Levofloxacin was found to be within the range of 99.3-100.3% respectively for Levofloxacin. This Analytical Procedure is applicable for the Quality Control of Drug Formulations

Key Words

Levofloxacin, Stationary Phase, Mobile Phase, HPLC, Validation, Phosphate Buffer, Acetonitrile

Cite This Article

"Development and Validation of HPLC Method for the Estimation of Levofloxacin in Bulk and Marketed Dosage form", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 4, page no.l326-l338, April-2024, Available :http://www.jetir.org/papers/JETIR2404B45.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Development and Validation of HPLC Method for the Estimation of Levofloxacin in Bulk and Marketed Dosage form", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 4, page no. ppl326-l338, April-2024, Available at : http://www.jetir.org/papers/JETIR2404B45.pdf

Publication Details

Published Paper ID: JETIR2404B45
Registration ID: 537827
Published In: Volume 11 | Issue 4 | Year April-2024
DOI (Digital Object Identifier):
Page No: l326-l338
Country: INDAPUR, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00019

Print This Page

Current Call For Paper

Jetir RMS